跳至主要内容
临床试验/NCT00121212
NCT00121212已完成不适用

Positron Emission Tomography in Prostate Cancer

Washington University School of Medicine2 个研究点 分布在 1 个国家目标入组 179 人开始时间: 2003年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
179
试验地点
2
主要终点
Determine the role of AC-PET in changing initial patient management

研究概览

简要总结

RATIONALE: Diagnostic procedures, such as positron emission tomography using carbon-11 acetate, may help find metastases from prostate cancer and may help predict whether prostate cancer will come back after treatment.

PURPOSE: This clinical trial is studying how well positron emission tomography using carbon-11 acetate works in finding metastases and predicting recurrence in patients with prostate cancer who are at risk for recurrence after treatment.

详细描述

The overall goal of this project is determination of the role of PET in patients with newly diagnosed medium- and high-risk prostate cancer in whom the standard clinical and imaging workup is negative. Thus, the incremental value of PET will be determined in this important group.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Determine the role of AC-PET in changing initial patient management

时间窗: Completion of patient treatment

次要结局

  • Determine the value of AC-PET in predicting recurrence(Minimum of 2 years and maximum of 5 years)
  • Assess the performance of AC-PET for detection of lymph node metastasis by comparison with biopsy.(Minimum of 2 years and maximum of 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验